Italian family’s inability to feel pain spurs research on relief for chronic sufferers

Chronic pain affects millions of people, who not only suffer but also risk becoming addicted to the opioid drugs used to treat it. A new report on six members of a three-generation Italian family who barely notice burns, bone breaks, and even red hot chili pepper extract rubbed into pricked skin, may pave the way to new painkillers — following clues from a single mutant gene.

The new report, published in the journal Brain, is from James Cox, PhD, senior lecturer in the Molecular Nociception Group at University College London (UCL) and colleagues. The featured family experiences very limited pain, unlike the famous case of a 10-year-old boy from Pakistan that I’ve included in every textbook edition I’ve written.

Cox and co-workers introduced the boy in a 2006 paper in Nature, “… a ten-year-old child, well known to the medical service after regularly performing ‘street theatre.’ He placed knives through his arms and walked on burning coals, but experienced no pain. He died before being seen on his fourteenth birthday, after jumping off a house roof.”

The title of that paper, “An SCN9A channelopathy causes congenital inability to experience pain,” tells the tale. The “disease of an ion channel” arises from abnormality of one of several types of proteins that form a channel in cell membranes that admits sodium ions. In the boy’s family, the mutant gene is SCN9A, and the encoded small protein, Nav1.7.

Sodium channel proteins control pain

At least ten genes encode sodium channel proteins, and mutations in them affect the sensation of pain. Mutations that hamper the functioning of the channels diminish pain, like in the Pakistani boy, whose body made too many endogenous opioids.pain 12 17 17 4

Mutations that rev up sodium channels do the opposite, causing “burning man syndrome” (erythermalgia) that makes putting on socks unbearable and “paroxysmal extreme pain disorder,” in which sodium channels stay open too long, causing excruciating pain in the rectum, jaw, and eyes.

The pain-free Pakistani boy and the almost-pain-free Italian family members have mutations in different protein parts of the sodium channels. Researchers from the University of Siena introduced the Italian Marsili family in 2008 in the journal Molecular Pain, which focused more on gene expression in white blood cells than on street performers like the Pakistani boy.

Cox picks up the story: “Around 2010, professor John Wood from UCL visited the Siena Pain School and met Letizia, a member of the family and also an associate professor at the university (and co-author of the 2008 paper) and learned more about her symptoms and those of the extended family. We took blood samples and began analyzing their DNA.” They sequenced exomes, the protein-encoding part of the genome.

The Marsilis barely noticed their oddity, just thinking something wasn’t quite right. A broken limb bone would cause a momentary startle, perhaps fleeting faintness, and then no pain. They could eat lots of red hot chili peppers with nary a flush. They didn’t notice burns until they looked at their skin. Yet their sense of smell was hyperacute, sometimes leading to vomiting in response to strong odors. And they didn’t sweat. Three other families are known to have what’s now called Marsili syndrome, and some of them have unwittingly bitten off fingers and lips.

The Marsili family consisted of a 78-year-old mother and two daughters — a 52-year-old with a 16-year-old daughter and a 50-year-old with 24- and 21-year-old sons. The mom, both daughters, and three grandchildren all experienced the dampened pain response. “Fortunately they haven’t suffered any serious injuries, apart from multiple bone fractures. This may be because they are not completely pain insensitive (unlike the SCN9A patients),” Cox said.

Poking and prodding in the lab

At the University of Siena, the researchers poked and prodded the Marsilis with pressure gauges on the sensitive area beneath the thumb, exposed their hands to superficial hot and cold, plunged their hands into ice water, and splayed sharp-tipped thingies called von Frey hairs across their inner forearms. Even capsaicin dripped into skin pricks didn’t make them shriek in pain, as most people would when so intimately exposed to chili pepper.

Yet the family members did feel pain not stemming from the body’s periphery: headache, backache, and labor pains. And they experienced deep pressure that would normally cause pain as pleasurable, like a massage.

Related article:  Blood disease that plagued Europe's royal families might be treatable using gene editing

Cox and his team zeroed in on a gene called ZFHX2 (zinc finger homeobox 2) behind the low pain sensitivity. A single DNA base change alters an arginine to a lysine, hampering the function of the sodium channel protein Nav1.9. Skin biopsies showed that the problem isn’t in the peripheral nerves, and gene expression studies led to the dorsal root ganglia (clustered nerve cell bodies) in the spinal cord. The nerve cells themselves are apparently undamaged — but their signaling appears compromised.

A cascade of gene activity

ZFHX2 encodes a giant protein that is a transcription factor – it controls suites of other genes. The mutation increases expression of six genes while decreasing expression of 16 others, several of them part of pain-signaling pathways and the sense of smell. And the fact that the affected part of the gene is exactly the same in DNA base sequence in a spectrum of species — chimps, dogs, cows, mice, rats, and frogs — indicates its importance.

In parallel to probing the pain-resistant people, the investigators bred mice that either lacked ZFHX2 (knockouts) or had two gene copies bearing the mutation sent in on a bacterial artificial chromosome, in addition to the animals’ own two functional copies (transgenics). Results with the knockouts were inconsistent, but the transgenic mice recapitulated some of the symptoms seen in the people the animals were sensitive to light touch, but didn’t seem to notice hits to their tails, withstood heat, and didn’t mind chili peppers. They also didn’t seem to enjoy massages as the people did. Dissecting spinal cords of the mice revealed the telltale altered gene expression in the dorsal root ganglia.

From mutation to drug discovery

The researchers call the study of the Italian family and others “a powerful route to identify novel analgesic drug targets,” perhaps by developing ways to selectively block sodium channels. “With more research to understand exactly how the mutation impacts pain sensitivity, and to see what other genes might be involved, we could identify novel targets for drug development,” said co-author Anna Maria Aloisi, MD, PhD, who was part of the team that initially identified the Marsili family’s condition and is co-author of the new paper.

But the route to a new analgesic isn’t straightforward, as Cox explained:

ZFHX2 encodes a transcription factor with enriched expression in damage-sensing neurons. Our focus is now to understand which are the critical genes that are dysregulated by the mutant transcription factor in relation to the pain insensitive phenotype. Some of the genes have known links to pain pathways, others are completely novel. In an ideal world, a single druggable downstream gene could be targeted as part of a drug development program, such as by a small molecule or gene therapy.”

Usually gene therapy introduces a functional copy of a gene to augment a disabled one, but in taking advantage of the pain-dampening mutation, gene therapy would actually deliver the mutant ZFHX2 gene into the spinal cord, which has already been done in some of the gene therapies I’ve written about. But the best vector, adeno-associated virus (AAV), isn’t big enough to accommodate the gargantuan ZFHX2 gene, a challenge also encountered in gene therapy to deliver the megagene dystrophin to treat muscular dystrophy. “One way around that would be to shorten the gene to see what bits we could lose and still retain function,” Cox told me.

With 10 percent of the world’s population more than 60 million people living with chronic pain, against the backdrop of minimizing prescription of opioids, a new approach to pain management is sorely needed. Perhaps the rare individuals with inherited diminished or absent pain sensations can help the many people suffering from chronic pain.

Ricki Lewis has a PhD in genetics and is a genetics counselor, science writer and author of The Forever Fix: Gene Therapy and the Boy Who Saved It, the only popular book about gene therapy . Follow her at her website or Twitter @rickilewis.

 

6 thoughts on “Italian family’s inability to feel pain spurs research on relief for chronic sufferers”

  1. This could have been reduced to a few paragraphs that I would have been able to share with my friends on social media. A short piece with a link to a longer one for those interested in more data, would aid in increasing science literacy. I will pick out the major points and pass them along to my friends.

    • Sometimes reducing an article to a tweet renders it impossible or at least improbable to communicate real knowledge. The kind of person who wont spend 4 minutes reading an article will likely read your tweet and come away knowing little more than they started.

      In fact they will consume a steady stream of factoids sufficient to divert their attention but insufficient to nourish their mind or their understanding of the world.

      Its simple enough to explain in a few paragraphs that you wasted everyone’s time by commenting thusly but I think the topic at hand probably deserved a few more words.

      • I am a retired. professional communicator. When I read the title of this newsletter, I conclude that it is aimed at achieving some level of literacy in the general public on the subject of genetics. Talking to people who are already literate and motivated to learn more is fine. But, if the goal is to increase public acceptance of the value of genetics, you have to talk to publics on their terms, in their language, not judge them for not already knowing what you want them to know or getting their information in methods and dosages of which you approve. I share your concerns with the poor quality of science (pseudo-science, mostly) that is abundant in most social media. In my opinion, the story about pain is one that is easily marketable to a larger audience, if it was packaged correctly.

    • Thanks for your comment Caird. I’m recovering from cancer surgery so didn’t see your comment until now. My background is very different from most science journalists because I am also a scientist, so I like to add info that goes beyond sound bytes. I also did an interview with the researcher — I didn’t just regurgitate the quotes from the news releases that everyone else does. You are of course entitled to your opinion but I try very hard to add perspective that other writers do not, and am very thankful for GLP for giving me that forum. I hate when the same basic info goes round and round a zillion ways with no context or perspective. I try not to do that.

      • My comment was not aimed at you, but at the editors. I think that reaching more people requires understanding them. Feeding them terse, factual and interesting bites, instead the whole sandwich would be a better approach, in my experience. One approach would be shorter stories, written in less technical language, linked to the type of informative story you wrote for the more advanced reader. Otherwise, this site just becomes another echo-chamber.

Leave a Comment

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend